The Plasma NAD+ Metabolome Is Dysregulated in "Normal" Aging
- PMID: 30124109
- PMCID: PMC6482912
- DOI: 10.1089/rej.2018.2077
The Plasma NAD+ Metabolome Is Dysregulated in "Normal" Aging
Abstract
Nicotinamide adenine dinucleotide (NAD+) is an essential pyridine nucleotide that serves as an electron carrier in cellular metabolism and plays a crucial role in the maintenance of balanced redox homeostasis. Quantification of NAD+:NADH and NADP+:NADPH ratios are pivotal to a wide variety of cellular processes, including intracellular secondary messenger signaling by CD38 glycohydrolases, DNA repair by poly(adenosine diphosphate ribose) polymerase (PARP), epigenetic regulation of gene expression by NAD-dependent histone deacetylase enzymes known as sirtuins, and regulation of the oxidative pentose phosphate pathway. We quantified changes in the NAD+ metabolome in plasma samples collected from consenting healthy human subjects across a wide age range (20-87 years) using liquid chromatography coupled to tandem mass spectrometry. Our data show a significant decline in the plasma levels of NAD+, NADP+, and other important metabolites such as nicotinic acid adenine dinucleotide (NAAD) with age. However, an age-related increase in the reduced form of NAD+ and NADP+-NADH and NADPH-and nicotinamide (NAM), N-methyl-nicotinamide (MeNAM), and the products of adenosine diphosphoribosylation, including adenosine diphosphate ribose (ADPR) was also reported. Whereas, plasma levels of nicotinic acid (NA), nicotinamide mononucleotide (NMN), and nicotinic acid mononucleotide (NAMN) showed no statistically significant changes across age groups. Taken together, our data cumulatively suggest that age-related impairments are associated with corresponding alterations in the extracellular plasma NAD+ metabolome. Our future research will seek to elucidate the role of modulating NAD+ metabolites in the treatment and prevention of age-related diseases.
Keywords: NAD; aging; biomarker; nicotinamide; plasma.
Conflict of interest statement
No competing financial interests exist.
Figures
Similar articles
-
TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activity.MAbs. 2022 Jan-Dec;14(1):2095949. doi: 10.1080/19420862.2022.2095949. MAbs. 2022. PMID: 35867844 Free PMC article.
-
Quantifying the cellular NAD+ metabolome using a tandem liquid chromatography mass spectrometry approach.Metabolomics. 2017 Dec 23;14(1):15. doi: 10.1007/s11306-017-1310-z. Metabolomics. 2017. PMID: 30830318 Free PMC article.
-
Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes.Antioxid Redox Signal. 2019 Jan 10;30(2):251-294. doi: 10.1089/ars.2017.7269. Epub 2018 May 11. Antioxid Redox Signal. 2019. PMID: 29634344 Free PMC article. Review.
-
A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD.Front Aging Neurosci. 2019 Sep 12;11:257. doi: 10.3389/fnagi.2019.00257. eCollection 2019. Front Aging Neurosci. 2019. PMID: 31572171 Free PMC article.
-
Enzymology of Ca2+-Mobilizing Second Messengers Derived from NAD: From NAD Glycohydrolases to (Dual) NADPH Oxidases.Cells. 2023 Feb 20;12(4):675. doi: 10.3390/cells12040675. Cells. 2023. PMID: 36831342 Free PMC article. Review.
Cited by
-
Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men.NPJ Aging. 2022 May 1;8(1):5. doi: 10.1038/s41514-022-00084-z. NPJ Aging. 2022. PMID: 35927255 Free PMC article.
-
Transfer of the longevity-associated variant of BPIFB4 gene rejuvenates immune system and vasculature by a reduction of CD38+ macrophages and NAD+ decline.Cell Death Dis. 2022 Jan 27;13(1):86. doi: 10.1038/s41419-022-04535-z. Cell Death Dis. 2022. PMID: 35087020 Free PMC article.
-
Interactions between Intestinal Homeostasis and NAD+ Biology in Regulating Incretin Production and Postprandial Glucose Metabolism.Nutrients. 2023 Mar 20;15(6):1494. doi: 10.3390/nu15061494. Nutrients. 2023. PMID: 36986224 Free PMC article. Review.
-
Enzymology of extracellular NAD metabolism.Cell Mol Life Sci. 2021 Apr;78(7):3317-3331. doi: 10.1007/s00018-020-03742-1. Epub 2021 Mar 23. Cell Mol Life Sci. 2021. PMID: 33755743 Free PMC article. Review.
-
The role of the tryptophan-NAD + pathway in a mouse model of severe malnutrition induced liver dysfunction.Nat Commun. 2022 Dec 8;13(1):7576. doi: 10.1038/s41467-022-35317-y. Nat Commun. 2022. PMID: 36481684 Free PMC article.
References
-
- Garrido A, Djouder N. NAD(+) Deficits in age-related diseases and cancer. Trends Cancer 2017;3:593–610 - PubMed
-
- Braidy N, Poljak A, Grant R, et al. . Mapping NAD(+) metabolism in the brain of ageing Wistar rats: Potential targets for influencing brain senescence. Biogerontology 2014;15:177–198 - PubMed
-
- Caruso R, Campolo J, Dellanoce C, et al. . Critical study of preanalytical and analytical phases of adenine and pyridine nucleotide assay in human whole blood. Anal Biochem 2004;330:43–51 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
